Versant Capital Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,596
| Closed | -$347K | – | 2799 |
|
|
2026
Q1 | $347K | Buy |
4,596
+264
| +6% | +$19.8K | 0.03% | 381 |
|
|
2025
Q4 | $323K | Buy |
4,332
+3,376
| +353% | +$247K | 0.04% | 334 |
|
|
2025
Q3 | $64.5K | Buy |
956
+383
| +67% | +$25.4K | 0.01% | 913 |
|
|
2025
Q2 | $37.3K | Sell |
573
-802
| -58% | -$48.1K | 0.01% | 1147 |
|
|
2025
Q1 | $84.9K | Buy |
1,375
+1,305
| +1,864% | +$86.5K | 0.01% | 679 |
|
|
2024
Q4 | $5.05K | Buy |
+70
| New | +$5.47K | ﹤0.01% | 1755 |
|
|
2024
Q3 | – | Sell |
-58
| Closed | -$4.31K | – | 2045 |
|
|
2024
Q2 | $4.31K | Hold |
58
| – | – | ﹤0.01% | 1266 |
|
|
2024
Q1 | $4.52K | Hold |
58
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q4 | $4.14K | Buy |
58
+8
| +16% | +$557 | ﹤0.01% | 1033 |
|
|
2023
Q3 | $3.47K | Sell |
50
-17
| -25% | -$1.28K | ﹤0.01% | 1111 |
|
|
2023
Q2 | $5.42K | Buy |
67
+17
| +34% | +$1.39K | ﹤0.01% | 1013 |
|
|
2023
Q1 | $4.04K | Hold |
50
| – | – | ﹤0.01% | 1019 |
|
|
2022
Q4 | $3.74K | Hold |
50
| – | – | ﹤0.01% | 976 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 982 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 989 |
|
|
2022
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 948 |
|
|
2021
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 958 |
|
|
2021
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 954 |
|
|
2021
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 1047 |
|
|
2021
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 1095 |
|
|
2020
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 1046 |
|
|
2020
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 982 |
|
|
2020
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 1058 |
|
|
2020
Q1 | $1K | Sell |
50
-70
| -58% | -$3.33K | ﹤0.01% | 1148 |
|
|
2019
Q4 | $6K | Sell |
120
-45
| -27% | -$2.24K | ﹤0.01% | 875 |
|
|
2019
Q3 | $8K | Sell |
165
-5
| -3% | -$246 | ﹤0.01% | 792 |
|
|
2019
Q2 | $8K | Hold |
170
| – | – | ﹤0.01% | 812 |
|
|
2019
Q1 | $8K | Hold |
170
| – | – | ﹤0.01% | 975 |
|
|
2018
Q4 | $6K | Hold |
170
| – | – | ﹤0.01% | 968 |
|
|
2018
Q3 | $6K | Hold |
170
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q2 | $6K | Hold |
170
| – | – | ﹤0.01% | 1029 |
|
|
2018
Q1 | $6K | Buy |
170
+5
| +3% | +$202 | ﹤0.01% | 1026 |
|
|
2017
Q4 | $7K | Buy |
165
+49
| +42% | +$1.95K | ﹤0.01% | 1026 |
|
|
2017
Q3 | $4K | Hold |
116
| – | – | ﹤0.01% | 1104 |
|
|
2017
Q2 | $5K | Hold |
116
| – | – | ﹤0.01% | 1050 |
|
|
2017
Q1 | $4K | Hold |
116
| – | – | ﹤0.01% | 1094 |
|
|
2016
Q4 | $4K | Sell |
116
-19
| -14% | -$733 | ﹤0.01% | 1060 |
|
|
2016
Q3 | $5K | Buy |
135
+39
| +41% | +$1.47K | ﹤0.01% | 985 |
|
|
2016
Q2 | $3K | Buy |
96
+13
| +16% | +$450 | ﹤0.01% | 1070 |
|
|
2016
Q1 | $2K | Hold |
83
| – | – | ﹤0.01% | 1129 |
|
|
2015
Q4 | $3K | Buy |
+83
| New | +$3.23K | ﹤0.01% | 1051 |
|
Other funds holding HOLX
Versant Capital Management's HOLX Position: Q2 2026 in Review
Versant Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,596 shares — an estimated $347K sold.
Versant Capital Management first reported a position in HOLX in Q4 2015 and held it in 41 quarters. The position peaked at $347K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Versant Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Versant Capital Management sold 4,596 Hologic shares in Q2 2026, an estimated $347K.
- Versant Capital Management first reported a position in Hologic in Q4 2015 and held it in 41 quarters.
- Versant Capital Management's Hologic position peaked at $347K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.